Literature DB >> 30785052

Demographic and nap-related variance of the MSLT: results from 2,498 suspected hypersomnia patients: Clinical MSLT variance.

Alyssa Cairns1, Lynn Marie Trotti2, Richard Bogan3.   

Abstract

OBJECTIVE: The purpose of this study was to enhance our understanding of clinical trends in sleep and rapid eye movement (REM) propensity on the multiple sleep latency test (MSLT). Demographic variables of interest included early childhood/advanced age, gender, race, and REM-suppressant use.
METHODS: Nocturnal sleep studies and 5-nap MSLTs were retrieved from a large repository of deidentified studies from various US sleep clinics between 2007 and 2015. Studies were signal processed, human-edited, and underwent rigorous quality assurance for inclusion.
RESULTS: The final sample consisted of N = 2498 MSLTs (24.2% Black; 34.2% Men; Age 4-89). In adults (age ≥ 21), sleep propensity modestly decreased across nap (90% at nap 1 to 80% at nap 5; p < 0.001). Children ≤12 years were least likely to fall asleep on any nap (∼55% at nap 5). REM propensity troughed at nap 4 (13%) and varied with age. Advanced age (≥60 years; OR: 0.28, p < 0.001), REM-suppressant use (OR:0.52, p < 0.001), and female sex (men OR: 1.48, p = 0.012) was associated with a decreased proportion of ≥2 REMs in adjusted logistic models. Children often demonstrated only 1 REM and generally had long sleep latencies, yielding a low proportion of MSLTs consistent with narcolepsy (11.0% vs. 19.2% and 16.8% in those between 13-20 and 21-59, respectively; p = 0.003).
CONCLUSIONS: MSLT outcomes vary greatly across age, gender, and use of psychotropic medication. Demographic variance should be considered when interpreting MSLT results. Robust age effect question the appropriateness of the MSLT as currently designed and implemented for children and older adults.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age; Gender; Hypersomnia; MSLT; Narcolepsy

Year:  2018        PMID: 30785052      PMCID: PMC6411434          DOI: 10.1016/j.sleep.2018.12.013

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  7 in total

1.  Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry.

Authors:  Lynn Marie Trotti; Jason C Ong; David T Plante; Catherine Friederich Murray; Rebecca King; Donald L Bliwise
Journal:  Sleep Med       Date:  2020-09-02       Impact factor: 3.492

2.  Multimodal assessment increases objective identification of hypersomnolence in patients referred for multiple sleep latency testing.

Authors:  David T Plante; Jesse D Cook; Michael L Prairie
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

3.  Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency.

Authors:  Bhanu Prakash Kolla; Marjan Jahani Kondori; Michael H Silber; Hala Samman; Swati Dhankikar; Meghna P Mansukhani
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

4.  Multiple Sleep Latency Test: when are 4 naps enough?

Authors:  John Goddard; George Tay; Jennifer Fry; Mark Davis; Deanne Curtin; Irene Szollosi
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

5.  Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine.

Authors:  Lois E Krahn; Donna L Arand; Alon Y Avidan; David G Davila; William A DeBassio; Chad M Ruoff; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.324

6.  Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.

Authors:  Jari K Gool; Zhongxing Zhang; Martijn S S L Oei; Stephanie Mathias; Yves Dauvilliers; Geert Mayer; Giuseppe Plazzi; Rafael Del Rio-Villegas; Joan Santamaria Cano; Karel Šonka; Markku Partinen; Sebastiaan Overeem; Rosa Peraita-Adrados; Raphael Heinzer; Antonio Martins da Silva; Birgit Högl; Aleksandra Wierzbicka; Anna Heidbreder; Eva Feketeova; Mauro Manconi; Jitka Bušková; Francesca Canellas; Claudio L Bassetti; Lucie Barateau; Fabio Pizza; Markus H Schmidt; Rolf Fronczek; Ramin Khatami; Gert Jan Lammers
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

7.  A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients.

Authors:  Aljohara S Almeneessier; Nouf S Alballa; Budoor H Alsalman; Salih Aleissi; Awad H Olaish; Ahmed S BaHammam
Journal:  Nat Sci Sleep       Date:  2019-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.